Brio Capital Master Fund Ltd. 13D and 13G filings for Biodexa Pharmaceuticals Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-20 11:56 am Purchase |
2024-11-14 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Brio Capital Master Fund Ltd. | 167,681 0.900% |
110,567 (+193.59%) |
Filing |
| 2024-07-23 3:09 pm Purchase |
2024-07-15 | 13G | Biodexa Pharmaceuticals Plc BDRX |
Brio Capital Master Fund Ltd. | 57,114 9.830% |
57,114 (New Position) |
Filing |